Abiopharma

New Form 4 - Galecto, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088162 Size: 5 KB

New Form 4 - Galecto, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088163 Size: 5 KB

IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous stem cell transplant

Axsome Therapeutics Champions Brain Health During Alzheimers & Brain Awareness Month

New Form 6-K - Haleon plc Filed: 2025-06-20 AccNo: 0001654954-25-007209 Size: 34 KB

Exelixis’ Partner Ipsen Receives Positive CHMP Opinion for CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors

New Form IRANNOTICE - Medtronic plc Filed: 2025-06-20 AccNo: 0001613103-25-000092 Size: 6 KB

New Form 10-K - Medtronic plc Filed: 2025-06-20 AccNo: 0001613103-25-000091 Size: 24 MB

New Form 6-K - AURORA CANNABIS INC Filed: 2025-06-20 AccNo: 0001279569-25-000645 Size: 46 KB

New Form 4 - Silence Therapeutics plc Filed: 2025-06-20 AccNo: 0001104659-25-060862 Size: 7 KB

Evolent reiterates Q2 and full year guidance for Adjusted EBITDA

New Form 8-K - Evolent Health, Inc. Filed: 2025-06-20 AccNo: 0001628908-25-000098 Size: 311 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Madrigal Receives Positive CHMP Opinion for Resmetirom(Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis

New Form 8-K - PetVivo Holdings, Inc. Filed: 2025-06-20 AccNo: 0001641172-25-015708 Size: 544 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

New Form 8-K - PROVECTUS BIOPHARMACEUTICALS, INC. Filed: 2025-06-20 AccNo: 0001641172-25-015695 Size: 208 KB Item 5.07: Submission of Matters to a Vote of Security Holders